Last update 08 May 2025

Eustralis Pharmaceuticals Ltd.

Private Company|Australia

Overview

Related

2
Drugs associated with Eustralis Pharmaceuticals Ltd.
Imnopitant
Target
NK1R
Mechanism
NK1R antagonists
Active Org.-
Originator Org.
F. Hoffmann-La Roche Ltd.
Active Indication-
Inactive Indication
Brain Injuries, Traumatic
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
EU-C-003
Target-
Mechanism-
Active Org.-
Originator Org.
Eustralis Pharmaceuticals Ltd.
Active Indication-
Inactive Indication
Neoplasms
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Eustralis Pharmaceuticals Ltd.
EUCTR2017-004890-15-GB
/ Unknown statusPhase 2
A double-blind placebo-controlled study with an open-label pilot phase, assessing the efficacy, tolerability and safety of EU-C-001 in patients with moderate to severe traumatic brain injury - PANGEA
ACTRN12618000364279
/ CompletedPhase 1
A Phase I study to investigate pharmacokinetics, safety, and tolerability of two single doses of EU-C-001 given as slow intravenous infusions in healthy female subjects
100 Clinical Results associated with Eustralis Pharmaceuticals Ltd.
Login to view more data
0 Patents (Medical) associated with Eustralis Pharmaceuticals Ltd.
Login to view more data
100 Deals associated with Eustralis Pharmaceuticals Ltd.
Login to view more data
100 Translational Medicine associated with Eustralis Pharmaceuticals Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Imnopitant
 ( NK1R )		Brain Injuries, Traumatic
More
Pending
EU-C-003
Neoplasms
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free